Page 3 - Best Small intestine cancer doctors: TOP 100 doctors

Dr. Klauzner is recognized as one of Israel's best Whipple surgeons – a complex procedure for tumors in the digestive system. He leads the surgery department at Sourasky Medical Center (Ichilov).

• Specializes in gastrointestinal, pancreatic, and colorectal cancer surgeries
• Over 45 years of surgical experience
• Holds the senior position of Chairman of Surgery

Prof. Oldhafer is a leading expert in liver, pancreatic, and stomach cancer surgery at Asklepios Hospital Barmbek. He heads the Centre for Liver Diseases, specializing in complex cases.

• Specializes in computer-navigated liver surgery and metastasis operations
• Uses advanced techniques like the ultrasonic knife
• Works with a multidisciplinary team of oncology and radiology specialists
• Focuses on minimally invasive abdominal surgeries

Prof. Elke Jaeger is one of Germany's top oncologists according to Focus rating, specializing in sarcoma at Nordwest Clinic.

• Head of Oncology and Hematology at Nordwest Clinic
• 35+ years of experience in oncology practice
• Recognized specialist in sarcoma treatment

Dr. Yildiz specializes in gastroenteropancreatic neuroendocrine tumors, with a decade of research and clinical experience at Medipol Mega University Hospital.

• Published 17+ peer-reviewed articles on neuroendocrine tumors and related conditions
• Expertise in diagnosing and managing rare paraneoplastic syndromes
• Active researcher with contributions to oncology and endocrinology journals

Dr. Alemdar specializes in small intestine cancer with extensive training in medical oncology at Akdeniz University.

• Board-certified in medical oncology since 2018
• Over 15 years of experience in internal medicine and oncology
• Worked at Akdeniz University Hospital – a leading oncology center
• Member of the Turkish Medical Oncology Association

Professor Mustafa Ondzhel specializes in oncosurgery, with a focus on colorectal and small intestine cancers at Medipol Mega University Hospital.

• Trained at the Cleveland Clinic in proctology and oncosurgery
• Board-certified by the European Commission on Coloproctology
• Published research on laparoscopic resection of rectal adenocarcinoma
• Head of the Department of Surgery at Istanbul Medipol University
• Recipient of the 'Most Successful Scientist of the Year' award in healthcare

As an Associate Professor and former Deputy Head of Oncology at the Medical University of Vienna, Prof. Köstler focuses on targeted, personalized cancer medicine.

• Over two decades specializing in medical oncology
• Expertise in biomarker development and resistance mechanisms
• Senior consultant specializing in solid tumor oncology at Wiener Privatklinik
• Published research in leading international journals

Professor Michele Reni coordinates AIOM guidelines for pancreatic cancer treatment – ensuring his methods align with Italy's top standards.

• Over 30 years specializing in gastro-esophageal and pancreatic cancers
• Director of Pancreas Center at San Raffaele – a leading oncology unit
• Published 180+ papers on innovative cancer treatments
• Leads clinical trials for metastatic pancreatic cancer patients

Chief Physician at a certified interdisciplinary cancer center – Phd Viola Fox specializes in comprehensive tumor treatments, including immunotherapy and molecular diagnostics.

• Expert in chemotherapy, immunotherapy, and targeted therapies
• Active in molecular biology research for innovative cancer treatments
• Member of German and American oncology societies
• Specialized in genetics since 2016

Assoc. Prof. Dr. Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over a decade of experience in oncology
• Former physician at Ankara Oncology Clinic
• Associate Professor since 2016
• Trained at Selcuk University Faculty of Medicine

Prof. Keil specializes in advanced imaging techniques for small intestine cancer – using MRI, CT, and ultrasound at Medical Center in Solingen.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Over 15 years of experience in interventional radiology
• Former leading doctor at University Hospital of Aachen
• Performs full range of diagnostic and interventional procedures

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Nail Paksoy specializes in gastrointestinal cancers at Medipol Bahçelievler Hospital, with a focus on small intestine cancer.

• ESMO Board Certified in Medical Oncology
• Subinvestigator in 8 international clinical trials for cancer treatments
• Published multiple research papers on gastrointestinal and rare cancers
• Fellowship-trained at Istanbul University Oncology Institute

Professor in Radiation Oncology with 20+ years specializing in cancer treatment – now at Istanbul Medipol University.

• Trained at Istanbul University and Kadir Has University
• Associate Professor then full Professor at Demiroglu Bilim University
• Works in radiation oncology departments at leading Istanbul hospitals
• Handles complex cases requiring precision radiation therapy

Dr. Ozden combines academic training at Istanbul University's distinguished Cerrahpaşa Faculty with 6 years specializing in medical oncology.

• Board-certified in internal medicine and medical oncology
• Trained at Kocaeli University – known for advanced cancer care
• Over 15 years of clinical practice across multiple hospitals

As an Associate Professor and published author, Babek Tabandeh brings advanced surgical expertise to cancer care at Medical Park Goztepe Hospital.

• Specializes in cancer surgery and minimally invasive (keyhole) procedures.
• Over 25 years of experience as a surgeon in leading Turkish hospitals.
• Faculty member at Bahçeşehir University's School of Medicine.
• Author or co-author of over 40 academic publications.
• Member of the prestigious American College of Surgeons.

Dr. Muzaffer Al specializes in laparoscopic surgery for small intestine cancer, with advanced training from Istanbul University's top medical programs.

• Board-certified surgeon with over 20 years of experience
• Expert in laparoscopic antireflux and bariatric surgery
• Trained in oncological cancer surgery at Cerrahpaşa Faculty of Medicine

Dr. Kinas specializes in complex gastrointestinal cancers, including small intestine cancer, at Büyük Anadolu Hospitals.

• Expertise in pancreatic and bile duct surgeries
• Performs oncological surgeries for various gastrointestinal cancers
• Skilled in advanced bariatric and metabolic procedures

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.